roflumilast COPD
Selected indexed studies
- Roflumilast for COPD. (Drugs Today (Barc), 2010) [PMID:21225021]
- Roflumilast: A Review in COPD. (Drugs, 2015) [PMID:26338438]
- Roflumilast: a review of its use in the treatment of COPD. (Int J Chron Obstruct Pulmon Dis, 2016) [PMID:26792988]
_Worker-drafted node — pending editorial review._
Connections
roflumilast COPD is a side effect of
Sources
- Roflumilast for COPD. (2010) pubmed
- Roflumilast: A Review in COPD. (2015) pubmed
- Roflumilast: a review of its use in the treatment of COPD. (2016) pubmed
- Roflumilast. (2012) pubmed
- Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap. (2018) pubmed
- The Role of the Pharmacist in Optimizing Outcomes With Roflumilast, a PDE4 Inhibitor for the Treatment of COPD. (2022) pubmed
- Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS. (2020) pubmed
- Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD. (2010) pubmed
- The use of roflumilast in COPD: a primary care perspective. (2010) pubmed
- Roflumilast in COPD. (2015) pubmed